XML 36 R19.htm IDEA: XBRL DOCUMENT v3.8.0.1
Earnings Per Common Share Attributable to Common Shareholders
 9 Months Ended
Oct. 01, 2017
Earnings Per Share [Abstract]  
Earnings Per Common Share Attributable to Common Shareholders Earnings Per Common Share Attributable to Common Shareholders
The following table provides the detailed calculation of Earnings per common share (EPS):
 
 
Three Months Ended
 
Nine Months Ended
(IN MILLIONS)
 
October 1,
2017

 
October 2,
2016

 
October 1,
2017

 
October 2,
2016

EPS Numerator––Basic
 
 
 
 
 
 
 
 
Income from continuing operations(a)
 
$
2,858

 
$
1,355

 
$
9,064

 
$
6,465

Less: Net income attributable to noncontrolling interests
 
18

 
—

 
32

 
25

Income from continuing operations attributable to Pfizer Inc.(a)
 
2,840

 
1,355

 
9,032

 
6,440

Less: Preferred stock dividends––net of tax
 
—

 
—

 
1

 
1

Income from continuing operations attributable to Pfizer Inc. common shareholders(a)
 
2,839

 
1,355

 
9,032

 
6,439

Discontinued operations––net of tax
 
—

 
—

 
1

 
—

Net income attributable to Pfizer Inc. common shareholders(a)
 
$
2,839

 
$
1,355

 
$
9,033

 
$
6,439

EPS Numerator––Diluted
 
 

 
 

 
 

 
 

Income from continuing operations attributable to Pfizer Inc. common shareholders and assumed conversions(a)
 
$
2,840

 
$
1,355

 
$
9,032

 
$
6,440

Discontinued operations––net of tax, attributable to Pfizer Inc. common shareholders and assumed conversions
 
—

 
—

 
1

 
—

Net income attributable to Pfizer Inc. common shareholders and assumed conversions(a)
 
$
2,840

 
$
1,355

 
$
9,034

 
$
6,440

EPS Denominator
 
 

 
 

 
 

 
 

Weighted-average number of common shares outstanding––Basic
 
5,951

 
6,066

 
5,972

 
6,095

Common-share equivalents: stock options, stock issuable under employee compensation plans, convertible preferred stock and accelerated share repurchase agreements(a)
 
89

 
84

 
85

 
80

Weighted-average number of common shares outstanding––Diluted(a)
 
6,041

 
6,150

 
6,057

 
6,175

Stock options that had exercise prices greater than the average market price of our common stock issuable under employee compensation plans(a), (b)
 
47

 
38

 
47

 
60

(a) 
Amounts for the third quarter and first nine months ended October 2, 2016 have been revised from previously reported amounts to reflect the adoption of a new accounting standard in the fourth quarter of 2016, as of January 1, 2016, that requires, when applying the treasury stock method for shares that could be repurchased, that the assumed proceeds no longer include the amount of excess tax benefit (see Note 1B).
(b) 
These common stock equivalents were outstanding for the periods presented, but were not included in the computation of diluted EPS for those periods because their inclusion would have had an anti-dilutive effect.